Kirsten Flowers is CCO & Chief Strategy Officer at Kura Oncology, Inc. (KURA). They have made 1 open-market trade across 1 company since 2023, most recently 2023-01-27.
CIK 0001797209
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2023, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KURA | SELL | 2023-01-27 | 2023-01-31 | $13.89 | $26K | -10.9% | -18.5% | -25.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.